世界の年鑑医薬品市場の概要、競合分析、予測、2018-2027年Global Almanac: Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 医薬品市場の概要、競合分析、予測、2018-2027年(世界年鑑) 概要 世界の医薬品産業プロファイルは、市場シェア、市場規模(2017~22年、2027年予測)など、トップラインの定性的および定量的サマリー情報... もっと見る
サマリー医薬品市場の概要、競合分析、予測、2018-2027年(世界年鑑)概要 世界の医薬品産業プロファイルは、市場シェア、市場規模(2017~22年、2027年予測)など、トップラインの定性的および定量的サマリー情報を提供します。また、主要な財務指標や市場内の競争圧力の分析を含む主要企業の説明も掲載しています。 主要ハイライト - 医薬品市場は医療用医薬品のみで構成され、コンシューマーヘルスケアやアニマルヘルスケアは含まれない。 - 市場価値は工場出荷価格(メーカーが流通業者に医薬品を販売する際の価格)で算出されている。 - - すべての市場データおよび予測は名目ベース(すなわち、インフレ調整なし)で表され、本レポートの作成に使用したすべての通貨換算は、恒常為替レート(2022年の年間平均為替レート)を用いて計算されている。 - 世界の医薬品市場の2022年の総売上高は1兆2,993億ドルで、2017年から2022年までの年平均成長率(CAGR)は5.5%であった。 - 2022年の世界医薬品市場におけるアジア太平洋地域のシェアは32.7%であった。世界の医薬品市場の成長は、主に中国やインドなどの新興市場の成長によるものである。新興市場は製薬企業に新たな機会をもたらす。 スコープ - 世界の医薬品市場の規模、成長、主要プレイヤーを特定することで、エントリーレベルの調査にかかる時間を短縮 - ファイブフォース分析により、世界の医薬品市場の競争力および魅力を把握 - 主要企業のプロフィールから、医薬品市場の主要プレイヤーのグローバル事業と財務実績の詳細を明らかにします。 - 世界の医薬品市場の今後の成長見通しを5年予測で把握することで、プレゼンテーションやピッチに重みを加えることができます 購入の理由 - 2022年の世界の医薬品市場規模は? - 2027年の医薬品世界市場規模は? - 世界の医薬品市場の競争力に影響を与える要因は何か? - 過去5年間の市場の推移は? - 世界の医薬品市場における上位競合企業は? 目次Table of Contents1 EXECUTIVE SUMMARY 1.1. Market value 1.2. Market value forecast 1.3. Geography segmentation 1.4. Market share 1.5. Competitive landscape 2 Introduction 2.1. What is this report about? 2.2. Who is the target reader? 2.3. How to use this report 2.4. Definitions 3 Global Pharmaceuticals 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in Asia-Pacific 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Pharmaceuticals in Europe 6.1. Market Overview 6.2. Market Data 6.3. Market Segmentation 6.4. Market outlook 6.5. Five forces analysis 7 Macroeconomic Indicators 7.1. Country data 8 Pharmaceuticals in France 8.1. Market Overview 8.2. Market Data 8.3. Market Segmentation 8.4. Market outlook 8.5. Five forces analysis 9 Macroeconomic Indicators 9.1. Country data 10 Pharmaceuticals in Germany 10.1. Market Overview 10.2. Market Data 10.3. Market Segmentation 10.4. Market outlook 10.5. Five forces analysis 11 Macroeconomic Indicators 11.1. Country data 12 Pharmaceuticals in Australia 12.1. Market Overview 12.2. Market Data 12.3. Market Segmentation 12.4. Market outlook 12.5. Five forces analysis 13 Macroeconomic Indicators 13.1. Country data 14 Pharmaceuticals in Brazil 14.1. Market Overview 14.2. Market Data 14.3. Market Segmentation 14.4. Market outlook 14.5. Five forces analysis 15 Macroeconomic Indicators 15.1. Country data 16 Pharmaceuticals in Canada 16.1. Market Overview 16.2. Market Data 16.3. Market Segmentation 16.4. Market outlook 16.5. Five forces analysis 17 Macroeconomic Indicators 17.1. Country data 18 Pharmaceuticals in China 18.1. Market Overview 18.2. Market Data 18.3. Market Segmentation 18.4. Market outlook 18.5. Five forces analysis 19 Macroeconomic Indicators 19.1. Country data 20 Pharmaceuticals in India 20.1. Market Overview 20.2. Market Data 20.3. Market Segmentation 20.4. Market outlook 20.5. Five forces analysis 21 Macroeconomic Indicators 21.1. Country data 22 Pharmaceuticals in Indonesia 22.1. Market Overview 22.2. Market Data 22.3. Market Segmentation 22.4. Market outlook 22.5. Five forces analysis 23 Macroeconomic Indicators 23.1. Country data 24 Pharmaceuticals in Italy 24.1. Market Overview 24.2. Market Data 24.3. Market Segmentation 24.4. Market outlook 24.5. Five forces analysis 25 Macroeconomic Indicators 25.1. Country data 26 Pharmaceuticals in Japan 26.1. Market Overview 26.2. Market Data 26.3. Market Segmentation 26.4. Market outlook 26.5. Five forces analysis 27 Macroeconomic Indicators 27.1. Country data 28 Pharmaceuticals in Mexico 28.1. Market Overview 28.2. Market Data 28.3. Market Segmentation 28.4. Market outlook 28.5. Five forces analysis 29 Macroeconomic Indicators 29.1. Country data 30 Pharmaceuticals in The Netherlands 30.1. Market Overview 30.2. Market Data 30.3. Market Segmentation 30.4. Market outlook 30.5. Five forces analysis 31 Macroeconomic Indicators 31.1. Country data 32 Pharmaceuticals in North America 32.1. Market Overview 32.2. Market Data 32.3. Market Segmentation 32.4. Market outlook 32.5. Five forces analysis 33 Pharmaceuticals in Russia 33.1. Market Overview 33.2. Market Data 33.3. Market Segmentation 33.4. Market outlook 33.5. Five forces analysis 34 Macroeconomic Indicators 34.1. Country data 35 Pharmaceuticals in Scandinavia 35.1. Market Overview 35.2. Market Data 35.3. Market Segmentation 35.4. Market outlook 35.5. Five forces analysis 36 Pharmaceuticals in Singapore 36.1. Market Overview 36.2. Market Data 36.3. Market Segmentation 36.4. Market outlook 36.5. Five forces analysis 37 Macroeconomic Indicators 37.1. Country data 38 Pharmaceuticals in South Africa 38.1. Market Overview 38.2. Market Data 38.3. Market Segmentation 38.4. Market outlook 38.5. Five forces analysis 39 Macroeconomic Indicators 39.1. Country data 40 Pharmaceuticals in South Korea 40.1. Market Overview 40.2. Market Data 40.3. Market Segmentation 40.4. Market outlook 40.5. Five forces analysis 41 Macroeconomic Indicators 41.1. Country data 42 Pharmaceuticals in Spain 42.1. Market Overview 42.2. Market Data 42.3. Market Segmentation 42.4. Market outlook 42.5. Five forces analysis 43 Macroeconomic Indicators 43.1. Country data 44 Pharmaceuticals in Turkey 44.1. Market Overview 44.2. Market Data 44.3. Market Segmentation 44.4. Market outlook 44.5. Five forces analysis 45 Macroeconomic Indicators 45.1. Country data 46 Pharmaceuticals in The United Kingdom 46.1. Market Overview 46.2. Market Data 46.3. Market Segmentation 46.4. Market outlook 46.5. Five forces analysis 47 Macroeconomic Indicators 47.1. Country data 48 Pharmaceuticals in The United States 48.1. Market Overview 48.2. Market Data 48.3. Market Segmentation 48.4. Market outlook 48.5. Five forces analysis 49 Macroeconomic Indicators 49.1. Country data 50 Company Profiles 50.1. Bayer AG 50.2. Novartis AG 50.3. Laboratoires Pierre Fabre SA 50.4. Boehringer Ingelheim GmbH 50.5. Ache Laboratorios Farmaceuticos SA 50.6. EMS Sigma Pharma 50.7. Apotex, Inc. 50.8. Yangtze River Pharmaceutical Group 50.9. Shanghai Pharmaceuticals Holding Co Ltd 50.10. Yunnan Baiyao Group Co Ltd 50.11. Guangzhou Pharmaceutical Holdings Ltd 50.12. Sun Pharmaceutical Industries Ltd 50.13. Lupin Ltd 50.14. Dr. Reddy's Laboratories Limited 50.15. Aurobindo Pharma Ltd 50.16. PT Kimia Farma Tbk 50.17. A Menarini Industrie Farmaceutiche Riunite Srl 50.18. Recordati S.p.A. 50.19. Chiesi Farmaceutici SpA 50.20. Daiichi Sankyo Co Ltd 50.21. Takeda Pharmaceutical Company Limited 50.22. Mitsubishi Tanabe Pharma Corporation 50.23. Genomma Lab Internacional SAB de CV 50.24. Les Laboratoires Servier 50.25. F. Hoffmann-La Roche Ltd 50.26. Astellas Pharma Inc. 50.27. Aspen Pharmacare Holdings Ltd 50.28. Adcock Ingram Holdings Ltd 50.29. Chong Kun Dang Pharmaceutical Corp. 50.30. Daewoong Pharmaceutical Co Ltd 50.31. Hanmi Pharmaceuticals Co Ltd 50.32. Almirall S.A. 50.33. Sanofi SA 50.34. Abdi Ibrahim Ilac Sanayi ve Ticaret AS 50.35. GSK plc. 50.36. Johnson & Johnson 50.37. Merck & Co., Inc. 50.38. Pfizer Inc. 50.39. AstraZeneca PLC 51 Appendix 51.1. Methodology 51.2. About MarketLine 図表リストList of TablesTable 1: Global pharmaceuticals market value: $ billion, 2017-22 Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2022 Table 3: Global pharmaceuticals market share: % share, by value, 2022 Table 4: Global pharmaceuticals market value forecast: $ billion, 2022–27 Table 5: Global size of population (million), 2018–22 Table 6: Global gdp (constant 2005 prices, $ billion), 2018–22 Table 7: Global gdp (current prices, $ billion), 2018–22 Table 8: Global inflation, 2018–22 Table 9: Global consumer price index (absolute), 2018–22 Table 10: Global exchange rate, 2018–22 Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22 Table 12: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2022 Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27 Table 14: Europe pharmaceuticals market value: $ billion, 2017-22 Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2022 Table 16: Europe pharmaceuticals market value forecast: $ billion, 2022–27 Table 17: Europe size of population (million), 2018–22 Table 18: Europe gdp (constant 2005 prices, $ billion), 2018–22 Table 19: Europe gdp (current prices, $ billion), 2018–22 Table 20: Europe inflation, 2018–22 Table 21: Europe consumer price index (absolute), 2018–22 Table 22: Europe exchange rate, 2018–22 Table 23: France pharmaceuticals market value: $ billion, 2017-22 Table 24: France pharmaceuticals market geography segmentation: $ billion, 2022 Table 25: France pharmaceuticals market value forecast: $ billion, 2022–27 Table 26: France size of population (million), 2018–22 Table 27: France gdp (constant 2005 prices, $ billion), 2018–22 Table 28: France gdp (current prices, $ billion), 2018–22 Table 29: France inflation, 2018–22 Table 30: France consumer price index (absolute), 2018–22 Table 31: France exchange rate, 2018–22 Table 32: Germany pharmaceuticals market value: $ billion, 2017-22 Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2022 Table 34: Germany pharmaceuticals market value forecast: $ billion, 2022–27 Table 35: Germany size of population (million), 2018–22 Table 36: Germany gdp (constant 2005 prices, $ billion), 2018–22 Table 37: Germany gdp (current prices, $ billion), 2018–22 Table 38: Germany inflation, 2018–22 Table 39: Germany consumer price index (absolute), 2018–22 Table 40: Germany exchange rate, 2018–22 Table 41: Australia pharmaceuticals market value: $ billion, 2017-22 Table 42: Australia pharmaceuticals market geography segmentation: $ billion, 2022 Table 43: Australia pharmaceuticals market value forecast: $ billion, 2022–27 Table 44: Australia size of population (million), 2018–22 Table 45: Australia gdp (constant 2005 prices, $ billion), 2018–22 Table 46: Australia gdp (current prices, $ billion), 2018–22 Table 47: Australia inflation, 2018–22 Table 48: Australia consumer price index (absolute), 2018–22 Table 49: Australia exchange rate, 2018–22 Table 50: Brazil pharmaceuticals market value: $ billion, 2017-22 Table 51: Brazil pharmaceuticals market geography segmentation: $ billion, 2022 Table 52: Brazil pharmaceuticals market value forecast: $ billion, 2022–27 Table 53: Brazil size of population (million), 2018–22 Table 54: Brazil gdp (constant 2005 prices, $ billion), 2018–22 Table 55: Brazil gdp (current prices, $ billion), 2018–22 Table 56: Brazil inflation, 2018–22 Table 57: Brazil consumer price index (absolute), 2018–22 Table 58: Brazil exchange rate, 2018–22 Table 59: Canada pharmaceuticals market value: $ billion, 2017-22 Table 60: Canada pharmaceuticals market geography segmentation: $ billion, 2022 Table 61: Canada pharmaceuticals market value forecast: $ billion, 2022–27 Table 62: Canada size of population (million), 2018–22 Table 63: Canada gdp (constant 2005 prices, $ billion), 2018–22 Table 64: Canada gdp (current prices, $ billion), 2018–22 Table 65: Canada inflation, 2018–22 Table 66: Canada consumer price index (absolute), 2018–22 Table 67: Canada exchange rate, 2018–22 Table 68: China pharmaceuticals market value: $ billion, 2017-22 Table 69: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 70: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 71: China size of population (million), 2018–22 Table 72: China gdp (constant 2005 prices, $ billion), 2018–22 Table 73: China gdp (current prices, $ billion), 2018–22 Table 74: China inflation, 2018–22 Table 75: China consumer price index (absolute), 2018–22 Table 76: China exchange rate, 2018–22 Table 77: India pharmaceuticals market value: $ billion, 2017-22 Table 78: India pharmaceuticals market geography segmentation: $ billion, 2022 Table 79: India pharmaceuticals market value forecast: $ billion, 2022–27 Table 80: India size of population (million), 2018–22 Table 81: India gdp (constant 2005 prices, $ billion), 2018–22 Table 82: India gdp (current prices, $ billion), 2018–22 Table 83: India inflation, 2018–22 Table 84: India consumer price index (absolute), 2018–22 Table 85: India exchange rate, 2018–22 Table 86: Indonesia pharmaceuticals market value: $ billion, 2017-22 Table 87: Indonesia pharmaceuticals market geography segmentation: $ billion, 2022 Table 88: Indonesia pharmaceuticals market value forecast: $ billion, 2022–27 Table 89: Indonesia size of population (million), 2018–22 Table 90: Indonesia gdp (constant 2005 prices, $ billion), 2018–22 Table 91: Indonesia gdp (current prices, $ billion), 2018–22 Table 92: Indonesia inflation, 2018–22 Table 93: Indonesia consumer price index (absolute), 2018–22 Table 94: Indonesia exchange rate, 2018–22 Table 95: Italy pharmaceuticals market value: $ billion, 2017-22 Table 96: Italy pharmaceuticals market geography segmentation: $ billion, 2022 Table 97: Italy pharmaceuticals market value forecast: $ billion, 2022–27 Table 98: Italy size of population (million), 2018–22 Table 99: Italy gdp (constant 2005 prices, $ billion), 2018–22 Table 100: Italy gdp (current prices, $ billion), 2018–22 Table 101: Italy inflation, 2018–22 Table 102: Italy consumer price index (absolute), 2018–22 Table 103: Italy exchange rate, 2018–22 Table 104: Japan pharmaceuticals market value: $ billion, 2017-22 Table 105: Japan pharmaceuticals market geography segmentation: $ billion, 2022
SummaryPharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 (Global Almanac) Table of ContentsTable of Contents1 EXECUTIVE SUMMARY 1.1. Market value 1.2. Market value forecast 1.3. Geography segmentation 1.4. Market share 1.5. Competitive landscape 2 Introduction 2.1. What is this report about? 2.2. Who is the target reader? 2.3. How to use this report 2.4. Definitions 3 Global Pharmaceuticals 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in Asia-Pacific 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Pharmaceuticals in Europe 6.1. Market Overview 6.2. Market Data 6.3. Market Segmentation 6.4. Market outlook 6.5. Five forces analysis 7 Macroeconomic Indicators 7.1. Country data 8 Pharmaceuticals in France 8.1. Market Overview 8.2. Market Data 8.3. Market Segmentation 8.4. Market outlook 8.5. Five forces analysis 9 Macroeconomic Indicators 9.1. Country data 10 Pharmaceuticals in Germany 10.1. Market Overview 10.2. Market Data 10.3. Market Segmentation 10.4. Market outlook 10.5. Five forces analysis 11 Macroeconomic Indicators 11.1. Country data 12 Pharmaceuticals in Australia 12.1. Market Overview 12.2. Market Data 12.3. Market Segmentation 12.4. Market outlook 12.5. Five forces analysis 13 Macroeconomic Indicators 13.1. Country data 14 Pharmaceuticals in Brazil 14.1. Market Overview 14.2. Market Data 14.3. Market Segmentation 14.4. Market outlook 14.5. Five forces analysis 15 Macroeconomic Indicators 15.1. Country data 16 Pharmaceuticals in Canada 16.1. Market Overview 16.2. Market Data 16.3. Market Segmentation 16.4. Market outlook 16.5. Five forces analysis 17 Macroeconomic Indicators 17.1. Country data 18 Pharmaceuticals in China 18.1. Market Overview 18.2. Market Data 18.3. Market Segmentation 18.4. Market outlook 18.5. Five forces analysis 19 Macroeconomic Indicators 19.1. Country data 20 Pharmaceuticals in India 20.1. Market Overview 20.2. Market Data 20.3. Market Segmentation 20.4. Market outlook 20.5. Five forces analysis 21 Macroeconomic Indicators 21.1. Country data 22 Pharmaceuticals in Indonesia 22.1. Market Overview 22.2. Market Data 22.3. Market Segmentation 22.4. Market outlook 22.5. Five forces analysis 23 Macroeconomic Indicators 23.1. Country data 24 Pharmaceuticals in Italy 24.1. Market Overview 24.2. Market Data 24.3. Market Segmentation 24.4. Market outlook 24.5. Five forces analysis 25 Macroeconomic Indicators 25.1. Country data 26 Pharmaceuticals in Japan 26.1. Market Overview 26.2. Market Data 26.3. Market Segmentation 26.4. Market outlook 26.5. Five forces analysis 27 Macroeconomic Indicators 27.1. Country data 28 Pharmaceuticals in Mexico 28.1. Market Overview 28.2. Market Data 28.3. Market Segmentation 28.4. Market outlook 28.5. Five forces analysis 29 Macroeconomic Indicators 29.1. Country data 30 Pharmaceuticals in The Netherlands 30.1. Market Overview 30.2. Market Data 30.3. Market Segmentation 30.4. Market outlook 30.5. Five forces analysis 31 Macroeconomic Indicators 31.1. Country data 32 Pharmaceuticals in North America 32.1. Market Overview 32.2. Market Data 32.3. Market Segmentation 32.4. Market outlook 32.5. Five forces analysis 33 Pharmaceuticals in Russia 33.1. Market Overview 33.2. Market Data 33.3. Market Segmentation 33.4. Market outlook 33.5. Five forces analysis 34 Macroeconomic Indicators 34.1. Country data 35 Pharmaceuticals in Scandinavia 35.1. Market Overview 35.2. Market Data 35.3. Market Segmentation 35.4. Market outlook 35.5. Five forces analysis 36 Pharmaceuticals in Singapore 36.1. Market Overview 36.2. Market Data 36.3. Market Segmentation 36.4. Market outlook 36.5. Five forces analysis 37 Macroeconomic Indicators 37.1. Country data 38 Pharmaceuticals in South Africa 38.1. Market Overview 38.2. Market Data 38.3. Market Segmentation 38.4. Market outlook 38.5. Five forces analysis 39 Macroeconomic Indicators 39.1. Country data 40 Pharmaceuticals in South Korea 40.1. Market Overview 40.2. Market Data 40.3. Market Segmentation 40.4. Market outlook 40.5. Five forces analysis 41 Macroeconomic Indicators 41.1. Country data 42 Pharmaceuticals in Spain 42.1. Market Overview 42.2. Market Data 42.3. Market Segmentation 42.4. Market outlook 42.5. Five forces analysis 43 Macroeconomic Indicators 43.1. Country data 44 Pharmaceuticals in Turkey 44.1. Market Overview 44.2. Market Data 44.3. Market Segmentation 44.4. Market outlook 44.5. Five forces analysis 45 Macroeconomic Indicators 45.1. Country data 46 Pharmaceuticals in The United Kingdom 46.1. Market Overview 46.2. Market Data 46.3. Market Segmentation 46.4. Market outlook 46.5. Five forces analysis 47 Macroeconomic Indicators 47.1. Country data 48 Pharmaceuticals in The United States 48.1. Market Overview 48.2. Market Data 48.3. Market Segmentation 48.4. Market outlook 48.5. Five forces analysis 49 Macroeconomic Indicators 49.1. Country data 50 Company Profiles 50.1. Bayer AG 50.2. Novartis AG 50.3. Laboratoires Pierre Fabre SA 50.4. Boehringer Ingelheim GmbH 50.5. Ache Laboratorios Farmaceuticos SA 50.6. EMS Sigma Pharma 50.7. Apotex, Inc. 50.8. Yangtze River Pharmaceutical Group 50.9. Shanghai Pharmaceuticals Holding Co Ltd 50.10. Yunnan Baiyao Group Co Ltd 50.11. Guangzhou Pharmaceutical Holdings Ltd 50.12. Sun Pharmaceutical Industries Ltd 50.13. Lupin Ltd 50.14. Dr. Reddy's Laboratories Limited 50.15. Aurobindo Pharma Ltd 50.16. PT Kimia Farma Tbk 50.17. A Menarini Industrie Farmaceutiche Riunite Srl 50.18. Recordati S.p.A. 50.19. Chiesi Farmaceutici SpA 50.20. Daiichi Sankyo Co Ltd 50.21. Takeda Pharmaceutical Company Limited 50.22. Mitsubishi Tanabe Pharma Corporation 50.23. Genomma Lab Internacional SAB de CV 50.24. Les Laboratoires Servier 50.25. F. Hoffmann-La Roche Ltd 50.26. Astellas Pharma Inc. 50.27. Aspen Pharmacare Holdings Ltd 50.28. Adcock Ingram Holdings Ltd 50.29. Chong Kun Dang Pharmaceutical Corp. 50.30. Daewoong Pharmaceutical Co Ltd 50.31. Hanmi Pharmaceuticals Co Ltd 50.32. Almirall S.A. 50.33. Sanofi SA 50.34. Abdi Ibrahim Ilac Sanayi ve Ticaret AS 50.35. GSK plc. 50.36. Johnson & Johnson 50.37. Merck & Co., Inc. 50.38. Pfizer Inc. 50.39. AstraZeneca PLC 51 Appendix 51.1. Methodology 51.2. About MarketLine List of Tables/GraphsList of TablesTable 1: Global pharmaceuticals market value: $ billion, 2017-22 Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2022 Table 3: Global pharmaceuticals market share: % share, by value, 2022 Table 4: Global pharmaceuticals market value forecast: $ billion, 2022–27 Table 5: Global size of population (million), 2018–22 Table 6: Global gdp (constant 2005 prices, $ billion), 2018–22 Table 7: Global gdp (current prices, $ billion), 2018–22 Table 8: Global inflation, 2018–22 Table 9: Global consumer price index (absolute), 2018–22 Table 10: Global exchange rate, 2018–22 Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22 Table 12: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2022 Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27 Table 14: Europe pharmaceuticals market value: $ billion, 2017-22 Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2022 Table 16: Europe pharmaceuticals market value forecast: $ billion, 2022–27 Table 17: Europe size of population (million), 2018–22 Table 18: Europe gdp (constant 2005 prices, $ billion), 2018–22 Table 19: Europe gdp (current prices, $ billion), 2018–22 Table 20: Europe inflation, 2018–22 Table 21: Europe consumer price index (absolute), 2018–22 Table 22: Europe exchange rate, 2018–22 Table 23: France pharmaceuticals market value: $ billion, 2017-22 Table 24: France pharmaceuticals market geography segmentation: $ billion, 2022 Table 25: France pharmaceuticals market value forecast: $ billion, 2022–27 Table 26: France size of population (million), 2018–22 Table 27: France gdp (constant 2005 prices, $ billion), 2018–22 Table 28: France gdp (current prices, $ billion), 2018–22 Table 29: France inflation, 2018–22 Table 30: France consumer price index (absolute), 2018–22 Table 31: France exchange rate, 2018–22 Table 32: Germany pharmaceuticals market value: $ billion, 2017-22 Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2022 Table 34: Germany pharmaceuticals market value forecast: $ billion, 2022–27 Table 35: Germany size of population (million), 2018–22 Table 36: Germany gdp (constant 2005 prices, $ billion), 2018–22 Table 37: Germany gdp (current prices, $ billion), 2018–22 Table 38: Germany inflation, 2018–22 Table 39: Germany consumer price index (absolute), 2018–22 Table 40: Germany exchange rate, 2018–22 Table 41: Australia pharmaceuticals market value: $ billion, 2017-22 Table 42: Australia pharmaceuticals market geography segmentation: $ billion, 2022 Table 43: Australia pharmaceuticals market value forecast: $ billion, 2022–27 Table 44: Australia size of population (million), 2018–22 Table 45: Australia gdp (constant 2005 prices, $ billion), 2018–22 Table 46: Australia gdp (current prices, $ billion), 2018–22 Table 47: Australia inflation, 2018–22 Table 48: Australia consumer price index (absolute), 2018–22 Table 49: Australia exchange rate, 2018–22 Table 50: Brazil pharmaceuticals market value: $ billion, 2017-22 Table 51: Brazil pharmaceuticals market geography segmentation: $ billion, 2022 Table 52: Brazil pharmaceuticals market value forecast: $ billion, 2022–27 Table 53: Brazil size of population (million), 2018–22 Table 54: Brazil gdp (constant 2005 prices, $ billion), 2018–22 Table 55: Brazil gdp (current prices, $ billion), 2018–22 Table 56: Brazil inflation, 2018–22 Table 57: Brazil consumer price index (absolute), 2018–22 Table 58: Brazil exchange rate, 2018–22 Table 59: Canada pharmaceuticals market value: $ billion, 2017-22 Table 60: Canada pharmaceuticals market geography segmentation: $ billion, 2022 Table 61: Canada pharmaceuticals market value forecast: $ billion, 2022–27 Table 62: Canada size of population (million), 2018–22 Table 63: Canada gdp (constant 2005 prices, $ billion), 2018–22 Table 64: Canada gdp (current prices, $ billion), 2018–22 Table 65: Canada inflation, 2018–22 Table 66: Canada consumer price index (absolute), 2018–22 Table 67: Canada exchange rate, 2018–22 Table 68: China pharmaceuticals market value: $ billion, 2017-22 Table 69: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 70: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 71: China size of population (million), 2018–22 Table 72: China gdp (constant 2005 prices, $ billion), 2018–22 Table 73: China gdp (current prices, $ billion), 2018–22 Table 74: China inflation, 2018–22 Table 75: China consumer price index (absolute), 2018–22 Table 76: China exchange rate, 2018–22 Table 77: India pharmaceuticals market value: $ billion, 2017-22 Table 78: India pharmaceuticals market geography segmentation: $ billion, 2022 Table 79: India pharmaceuticals market value forecast: $ billion, 2022–27 Table 80: India size of population (million), 2018–22 Table 81: India gdp (constant 2005 prices, $ billion), 2018–22 Table 82: India gdp (current prices, $ billion), 2018–22 Table 83: India inflation, 2018–22 Table 84: India consumer price index (absolute), 2018–22 Table 85: India exchange rate, 2018–22 Table 86: Indonesia pharmaceuticals market value: $ billion, 2017-22 Table 87: Indonesia pharmaceuticals market geography segmentation: $ billion, 2022 Table 88: Indonesia pharmaceuticals market value forecast: $ billion, 2022–27 Table 89: Indonesia size of population (million), 2018–22 Table 90: Indonesia gdp (constant 2005 prices, $ billion), 2018–22 Table 91: Indonesia gdp (current prices, $ billion), 2018–22 Table 92: Indonesia inflation, 2018–22 Table 93: Indonesia consumer price index (absolute), 2018–22 Table 94: Indonesia exchange rate, 2018–22 Table 95: Italy pharmaceuticals market value: $ billion, 2017-22 Table 96: Italy pharmaceuticals market geography segmentation: $ billion, 2022 Table 97: Italy pharmaceuticals market value forecast: $ billion, 2022–27 Table 98: Italy size of population (million), 2018–22 Table 99: Italy gdp (constant 2005 prices, $ billion), 2018–22 Table 100: Italy gdp (current prices, $ billion), 2018–22 Table 101: Italy inflation, 2018–22 Table 102: Italy consumer price index (absolute), 2018–22 Table 103: Italy exchange rate, 2018–22 Table 104: Japan pharmaceuticals market value: $ billion, 2017-22 Table 105: Japan pharmaceuticals market geography segmentation: $ billion, 2022
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
MarketLine 社の最新刊レポート本レポートと同じKEY WORD(competitive analysis)の最新刊レポートよくあるご質問MarketLine社はどのような調査会社ですか?マーケットライン(MarketLine)は、世界の産業および企業を国別や業種別に詳細に調査し、調査レポートを積極的に出版しています。また世界の企業を幅広く対象に様々な角度から調査した企業レポートも出版... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/09 10:27 143.78 円 159.73 円 191.51 円 |